ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BCDA BioCardia Inc

3.54
0.20 (5.99%)
Jun 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 202,951
Bid Price 3.50
Ask Price 3.65
News -
Day High 3.70

Low
3.20

52 Week Range

High
43.7985

Day Low 3.26
Share Name Share Symbol Market Stock Type
BioCardia Inc BCDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.20 5.99% 3.54 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.33 3.26 3.70 3.54 3.34
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,164 202,951 US$ 3.49 US$ 707,561 - 3.20 - 43.7985
Last Trade Type Quantity Price Currency
18:56:17 1 US$ 3.63 USD

BioCardia Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
76.32M 21.62M - 477k -11.57M -0.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioCardia News

Date Time Source News Article
6/07/202406:00GlobeNewswire Inc.BioCardia Announces United States Patent Issuance on..
5/21/202416:00GlobeNewswire Inc.BioCardia Announces Reverse Stock Split
5/14/202415:02GlobeNewswire Inc.BioCardia Reports First Quarter 2024 Business Highlights and..
5/01/202406:00GlobeNewswire Inc.BioCardia’s CardiAMP Cell Therapy Chronic Myocardial..
4/25/202408:00GlobeNewswire Inc.BioCardia Completes Enrollment of CardiAMP Cell Therapy for..
3/27/202415:00GlobeNewswire Inc.BioCardia Reports Fourth Quarter and Full Year 2023 Business..
3/20/202406:00GlobeNewswire Inc.BioCardia to Host 2023 Financial Results and Corporate..
3/13/202406:00GlobeNewswire Inc.BioCardia and StemCardia Announce Biotherapeutic Delivery..
3/12/202406:00GlobeNewswire Inc.BioCardia Announces CMS Approval of Coverage for CardiAMP..
3/04/202407:00Edgar (US Regulatory)Form 8-K - Current report
3/04/202407:00GlobeNewswire Inc.BioCardia Reports Positive Interim Results from Phase III..
2/27/202415:53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BCDA Message Board. Create One! See More Posts on BCDA Message Board See More Message Board Posts

Historical BCDA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.413.933.233.5179,1010.133.81%
1 Month6.00456.153.203.97462,500-2.46-41.04%
3 Months6.156.4053.204.65240,735-2.61-42.44%
6 Months9.33310.78953.206.11311,232-5.79-62.07%
1 Year36.1543.79853.2013.58840,133-32.61-90.21%
3 Years72.0076.4823.2021.47489,359-68.46-95.08%
5 Years78.60129.003.2045.36523,108-75.06-95.50%

BioCardia Description

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

Your Recent History

Delayed Upgrade Clock